British Columbia Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Sell |
|
|||||
|
2025
Q1 | $2.14M | Buy |
|
|||||
|
2024
Q4 | $2.64M | Buy |
|
|||||
|
2024
Q3 | $1.93M | Sell |
|
|||||
|
2024
Q2 | $2.62M | Buy |
|
|||||
|
2024
Q1 | $1.62M | Buy |
|
|||||
|
2023
Q4 | $1.48M | Buy |
|
|||||
|
2023
Q3 | $989K | Hold |
|
|||||
|
2023
Q2 | $829K | Buy |
|
|||||
|
2023
Q1 | $866K | Buy |
|
|||||
|
2022
Q4 | $1.01M | Sell |
|
|||||
|
2022
Q3 | $991K | Sell |
|
|||||
|
2022
Q2 | $1.07M | Sell |
|
|||||
|
2022
Q1 | $1.37M | Sell |
|
|||||
|
2021
Q4 | $1.41M | Sell |
|
|||||
|
2021
Q3 | $1.68M | Buy |
|
|||||
|
2021
Q2 | $1.69M | Buy |
|
|||||
|
2021
Q1 | $1.41M | Sell |
|
|||||
|
2020
Q4 | $1.43M | Sell |
|
|||||
|
2020
Q3 | $1.47M | Buy |
|
|||||
|
2020
Q2 | $1.71M | Buy |
|
|||||
|
2020
Q1 | $828K | Sell |
|
|||||
|
2019
Q4 | $2.2M | Buy |
|